
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
Viveon Health Acquisition Corp (VHAQ)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/30/2025: VHAQ (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -14.22% | Avg. Invested days 88 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 66.49M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta -0.11 | 52 Weeks Range 0.00 - 11.00 | Updated Date 02/28/2025 |
52 Weeks Range 0.00 - 11.00 | Updated Date 02/28/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.04 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -3.25% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 70541803 | Price to Sales(TTM) - |
Enterprise Value 70541803 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA 21.91 | Shares Outstanding 6648660 | Shares Floating 651929 |
Shares Outstanding 6648660 | Shares Floating 651929 | ||
Percent Insiders 88.47 | Percent Institutions 13.38 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Viveon Health Acquisition Corp.: An In-Depth Analysis
Company Profile:
History and Background: Viveon Health Acquisition Corp. (NASDAQ: VHC) is a blank check company incorporated in Delaware on February 26, 2021. The company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. As of November 2023, Viveon has not yet completed an initial business combination.
Core Business Areas: Viveon seeks to identify and acquire healthcare businesses, with an emphasis on the pharmaceutical industry. The company focuses on businesses in the commercial stage with revenue, profitability, and a strong market position.
Leadership Team:
- Chairman & Chief Executive Officer: John Bonfiglio
- President: Matthew Pauls
- Chief Financial Officer: David Smith
- Director and Advisor to CEO: John O'Neill Jr.
Corporate Structure: Viveon operates as a Delaware corporation with an executive team based in the United States.
Top Products and Market Share:
Products & Offerings: As a blank check company, Viveon doesn't currently have its own products or market share.
Financial Performance:
Revenue & Net Income: Viveon has not yet generated any revenue, as they haven't completed a business combination. Net income is also unavailable due to the lack of operations.
Profit Margins: Unavailable at present.
Earnings per Share (EPS): Unavailable at this time.
Financial Analysis: Due to the company's current stage, a complete financial analysis is not feasible.
Dividends and Shareholder Returns:
Dividend History: Viveon has not paid any dividends to date.
Shareholder Returns: As the company has yet to complete a merger and commence operations, shareholder return data is not available.
Growth Trajectory:
Historical Growth: Due to Viveon's status as a pre-merger entity, historical growth data is unavailable.
Future Growth Projections: Future growth projections are highly speculative at this stage, as they depend heavily on the target company Viveon eventually chooses to acquire.
Market Dynamics:
The healthcare industry is constantly evolving, with advancements in technology, changing demographics, and increased government regulation all shaping its future. Viveon, once it completes an acquisition, will have to navigate this complex landscape.
Competitors:
Key competitors in the blank check company space, along with their stock ticker symbols, include:
- Cassava Science (SAVA)
- Medical Properties Trust (MPW)
- Digital World Acquisition Corp. (DWAC)
- Xometry Inc. (XMTR)
- Molecular Templates, Inc. (MTEM)
Potential Challenges and Opportunities:
Key Challenges:
- Identifying a suitable target company to acquire.
- Successfully completing an initial business combination.
- Integrating the acquired business and creating value for shareholders.
- Successfully navigating the complexities of the healthcare market.
Potential Opportunities:
- Acquiring a business with strong growth potential and synergies with existing operations.
- Leveraging the expertise and resources of its management team to drive future growth and success.
- Utilizing its public listing to access capital for potential acquisitions and growth initiatives.
Recent Acquisitions:
As Viveon has not yet completed any acquisitions, this section is currently inapplicable.
AI-Based Fundamental Rating:
Rating: Due to Viveon's early-stage nature and limited publicly available data, providing a reliable AI-based fundamental rating is difficult.
Justification: An accurate AI model requires sufficient historical financial and operational data, which is unavailable for Viveon at this stage.
Sources and Disclaimers:
- Viveon Health Acquisition Corp. investor presentation: https://investors.viveonhealthcorp.com/static-files/12820232-29c7-4598-b474-414c379a3721
- SEC Filings: https://www.sec.gov/edgar/search?company=Viveon+Health+Acquisition+Corp.
- Data and information concerning Viveon is based on publicly available data and the analysis may change as new information emerges.
- This report is for informational purposes only and should not be considered financial advice.
Conclusion
Viveon Health Acquisition Corp. presents a unique investment opportunity as it seeks to combine with an established healthcare entity. While it's crucial to consider potential challenges and opportunities, Viveon's leadership team and focus on the commercially established healthcare space suggest the potential for successful growth and value creation.
It's important to note that this report offers a preliminary analysis of Viveon based on available data. Performing additional research and due diligence are strongly advised before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Viveon Health Acquisition Corp
Exchange NYSE MKT | Headquaters Atlanta, GA, United States | ||
IPO Launch date 2021-02-04 | CEO, President & Chairman of the Board Dr. Jagi Gill M.D., Ph.D. | ||
Sector Financial Services | Industry Shell Companies | Full time employees - | Website |
Full time employees - | Website |
Viveon Health Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in the healthcare industry in North America. The company was incorporated in 2020 and is based in Atlanta, Georgia. Viveon Health Acquisition Corp. operates as a subsidiary of Viveon Health LLC.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.